The 16th Canada-EU biotech market access issues dialogue

November, 6, 2024, by videoconference
09:00 – 12:00 (Ottawa) / 15:00 – 18:00 (Brussels)

Provisional agenda

1. Introductions and opening remarks
   Canadian Co-Chairs
   European Union (EU) Co-Chair
2. Genetically Modified (GM) event approvals: European Food Safety Authority (EFSA) assessment and timelines (CAN Issue)
   1. 2.1 Status of specific applications under EFSA assessment/post-EFSA approval
   2. 2.2 Pre and post EFSA assessment process and timelines-
3. EU stacked GM event approval process – clarification about timelines (CAN Issue)
4. Other policy updates related to biotechnology files (CAN Issue)
   Speaker: EU
   1. 4.1 Update on EU’s New Genomic Techniques regulation proposal (timelines and traceability/labelling requirements) (EU to provide)
   2. 4.2 Centers for Disease Control and Prevention (CDC) Triffid Protocol update (CAN to provide)

Health break

5. CAN policy updates (EU Issue)
   1. 5.1 Canadian Food Inspection Agency (CFIA) Update- Guidance on how to determine when a plant-derived ingredient requires a feed pre-market evaluation
6. Updates on international activities
7. Any other business
8. Closing remarks and next steps
   Canadian Co-Chairs
   EU Co-Chair